Cargando…

Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19

Detalles Bibliográficos
Autor principal: Jolobe, Oscar M.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141265/
https://www.ncbi.nlm.nih.gov/pubmed/34059386
http://dx.doi.org/10.1016/j.ajem.2021.05.053
_version_ 1783696330004103168
author Jolobe, Oscar M.P.
author_facet Jolobe, Oscar M.P.
author_sort Jolobe, Oscar M.P.
collection PubMed
description
format Online
Article
Text
id pubmed-8141265
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-81412652021-05-24 Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19 Jolobe, Oscar M.P. Am J Emerg Med Article Elsevier Inc. 2022-04 2021-05-23 /pmc/articles/PMC8141265/ /pubmed/34059386 http://dx.doi.org/10.1016/j.ajem.2021.05.053 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Jolobe, Oscar M.P.
Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19
title Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19
title_full Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19
title_fullStr Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19
title_full_unstemmed Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19
title_short Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19
title_sort extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141265/
https://www.ncbi.nlm.nih.gov/pubmed/34059386
http://dx.doi.org/10.1016/j.ajem.2021.05.053
work_keys_str_mv AT jolobeoscarmp extendingtheclinicalspectrumofthromboticthrombocytopenicsyndromeattributabletoadenovirusbasedvaccinesforcovid19